1. Home
  2. SPCE vs CDXS Comparison

SPCE vs CDXS Comparison

Compare SPCE & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$3.05

Market Cap

175.5M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.15

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
CDXS
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
175.5M
141.8M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
SPCE
CDXS
Price
$3.05
$2.15
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$3.26
N/A
AVG Volume (30 Days)
5.6M
3.2M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
60.84
43.82
EPS
N/A
N/A
Revenue
$1,544,000.00
$138,590,000.00
Revenue This Year
$2,766.13
$6.35
Revenue Next Year
$699.18
$16.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$2.13
$0.96
52 Week High
$5.59
$3.87

Technical Indicators

Market Signals
Indicator
SPCE
CDXS
Relative Strength Index (RSI) 67.41 73.88
Support Level $2.91 $1.57
Resistance Level $3.42 $2.56
Average True Range (ATR) 0.23 0.15
MACD 0.08 0.05
Stochastic Oscillator 77.31 96.33

Price Performance

Historical Comparison
SPCE
CDXS

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: